These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31112742)

  • 1. Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy of hyperthyroidism.
    Lino CA; Demasi M; Barreto-Chaves ML
    Mol Cell Endocrinol; 2019 Aug; 493():110451. PubMed ID: 31112742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased PGC1- α levels and increased apoptotic protein signaling are associated with the maladaptive cardiac hypertrophy in hyperthyroidism.
    Teixeira RB; Barboza TE; DE Araujo CC; Siqueira R; DE Castro AL; Bonetto JHP; DE Lima-Seolin BG; Carraro CC; Bello-Klein A; Singal PK; Araujo ASDR
    J Biosci; 2018 Dec; 43(5):887-895. PubMed ID: 30541949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.
    Diniz GP; Takano AP; Barreto-Chaves ML
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle.
    Nishiyama A; Kambe F; Kamiya K; Seo H; Toyama J
    Cardiovasc Res; 1998 Nov; 40(2):343-51. PubMed ID: 9893728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle.
    O'Neal P; Alamdari N; Smith I; Poylin V; Menconi M; Hasselgren PO
    J Cell Biochem; 2009 Nov; 108(4):963-73. PubMed ID: 19777444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.
    Senger N; Melo MB; Diniz GP; Campagnole-Santos MJ; Santos RAS; Barreto-Chaves MLM
    Clin Sci (Lond); 2018 Jun; 132(11):1117-1133. PubMed ID: 29685981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of a Non-Functional Thyroid Receptor Beta upon Triiodotironine-Induced Cardiac Hypertrophy in Mice.
    do Império GE; Ramos IP; Santiago LA; Pereira GF; dos Santos Almeida NA; Fuziwara CS; Pazos-Moura CC; Kimura ET; Olivares EL; Ortiga-Carvalho TM
    Cell Physiol Biochem; 2015; 37(2):477-90. PubMed ID: 26315584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy.
    Kinugawa K; Yonekura K; Ribeiro RC; Eto Y; Aoyagi T; Baxter JD; Camacho SA; Bristow MR; Long CS; Simpson PC
    Circ Res; 2001 Sep; 89(7):591-8. PubMed ID: 11577024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?
    Thomas MR; Miell JP; Taylor AM; Ross RJ; Arnao JR; Jewitt DE; McGregor AM
    J Mol Endocrinol; 1993 Jun; 10(3):313-23. PubMed ID: 8373515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy.
    Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
    Pflugers Arch; 2007 Apr; 454(1):75-81. PubMed ID: 17206447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload.
    Ranek MJ; Zheng H; Huang W; Kumarapeli AR; Li J; Liu J; Wang X
    J Mol Cell Cardiol; 2015 Aug; 85():273-81. PubMed ID: 26116868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic exercise training improves oxidative stress and ubiquitin proteasome system activity in heart of spontaneously hypertensive rats.
    de Andrade LH; de Moraes WM; Matsuo Junior EH; de Orleans Carvalho de Moura E; Antunes HK; Montemor J; Antonio EL; Bocalini DS; Serra AJ; Tucci PJ; Brum PC; Medeiros A
    Mol Cell Biochem; 2015 Apr; 402(1-2):193-202. PubMed ID: 25626892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.
    Diniz GP; Lino CA; Guedes EC; Moreira Ldo N; Barreto-Chaves ML
    Basic Res Cardiol; 2015 Sep; 110(5):49. PubMed ID: 26202011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac hypertrophy caused by hyperthyroidism in rats: the role of ATF-6 and TRPC1 channels.
    Bektur Aykanat NE; Şahin E; Kaçar S; Bağcı R; Karakaya Ş; Burukoğlu Dönmez D; Şahintürk V
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1226-1233. PubMed ID: 34283935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study.
    Atherton HJ; Dodd MS; Heather LC; Schroeder MA; Griffin JL; Radda GK; Clarke K; Tyler DJ
    Circulation; 2011 Jun; 123(22):2552-61. PubMed ID: 21606392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray.
    De K; Ghosh G; Datta M; Konar A; Bandyopadhyay J; Bandyopadhyay D; Bhattacharya S; Bandyopadhyay A
    J Endocrinol; 2004 Aug; 182(2):303-14. PubMed ID: 15283691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
    J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy.
    Shohet RV; Kisanuki YY; Zhao XS; Siddiquee Z; Franco F; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2088-93. PubMed ID: 14764893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study.
    Basset A; Blanc J; Messas E; Hagège A; Elghozi JL
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):163-72. PubMed ID: 11209999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.